 |
|
AEE788
An orally bioavailable multiple-receptor tyrosine kinase inhibitor. AEE788 inhibits phosphorylation of the tyrosine kinases of epidermal growth factor receptor (EGFR), human epidermal growth factor receptor 2 (HER2), and vascular endothelial growth factor receptor 2 (VEGF2), resulting in receptor inhibition, the inhibition of cellular proliferation, and induction of tumor cell and tumor-associated endothelial cell apoptosis. Check for active clinical trials or closed clinical trials using this agent. (NCI Thesaurus)
| Previous: | adozelesin, Adriamycin PFS, Adriamycin RDF, Adrucil, ADVEXIN | | Next: | AEG35156, Aeroseb-Dex, Aeroseb-HC, aerosol sargramostim, aerosolized liposomal 9-nitro-20 (S) camptothecin |
|
|
